These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 7536524

  • 1. In-vitro cell growth of human urothelial tumor cell lines under exposure with IL-3, GM-CSF, G-CSF and by combined administration with methotrexate, vinblastine, adriamycin and cisplatin.
    Block T, Treiber U, Geffken B, Vogel M, Hanauske AR, Busch R, Hartung R.
    Investig Urol (Berl); 1994; 5():91-4. PubMed ID: 7536524
    [No Abstract] [Full Text] [Related]

  • 2. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M.
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [Abstract] [Full Text] [Related]

  • 3. [The activity of etoposide (VP16) in combination chemotherapy against human bladder cancer cells in vitro].
    Hattori T, Satoh M, Terashima Y, Nishimura T, Akimoto M.
    Hinyokika Kiyo; 1991 Sep; 37(9):995-8. PubMed ID: 1785427
    [Abstract] [Full Text] [Related]

  • 4. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 5. Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
    Viens P, Gravis G, Bladou F, Lechevallier E, Baume D, Camerlo J, Cowen D, Coulange C, Serment G, Resbeut M, Maraninchi D.
    Eur Cytokine Netw; 1996 Sep; 7(3):395-9. PubMed ID: 8954183
    [Abstract] [Full Text] [Related]

  • 6. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A, De Felice L, Mascolo MG, Valentini T, Petrucci MT, Petti MC.
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [Abstract] [Full Text] [Related]

  • 7. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V.
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [Abstract] [Full Text] [Related]

  • 8. The effects of five hematopoietic growth factors on human small cell lung carcinoma cell lines: interleukin 3 enhances the proliferation in one of the eleven cell lines.
    Vellenga E, Biesma B, Meyer C, Wagteveld L, Esselink M, de Vries EG.
    Cancer Res; 1991 Jan 01; 51(1):73-6. PubMed ID: 1703041
    [Abstract] [Full Text] [Related]

  • 9. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving methotrexate/vinblastine/doxorubicin/cisplatin therapy for the treatment of transitional cell carcinoma of the urinary tract.
    Akaza H, Kotake T, Miyanaga N, Koiso K.
    Semin Oncol; 1994 Feb 01; 21(1 Suppl 1):70-4. PubMed ID: 7512280
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec 01; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 11. The cellular basis for enhancement interactions between stem cell factor and the colony stimulating factors.
    Metcalf D.
    Stem Cells; 1993 Jul 01; 11 Suppl 2():1-11. PubMed ID: 7691313
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul 01; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 13. [Activity of various hematopoietic growth factors on acute myeloblastic leukemia blasts].
    Almeida J, del Cañizo MC, Vidriales B, Hernández MD, Galende J, San Miguel J.
    Sangre (Barc); 1996 Feb 01; 41(1):3-8. PubMed ID: 8779032
    [Abstract] [Full Text] [Related]

  • 14. Stem cell factor and interleukin-6, alone or in combination with granulocyte colony-stimulating factor, do not affect the growth of solid tumor cell lines.
    Pedrazzoli P, Gibelli N, Poggi G, Zambelli A, Saverio F, Della Cuna R, Locatelli F, Zibera C.
    Anticancer Res; 1995 Feb 01; 15(1):25-8. PubMed ID: 7537486
    [Abstract] [Full Text] [Related]

  • 15. Effect of c-kit ligand (stem cell factor) in combination with interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3, on eosinophil lineage.
    Kobayashi H.
    Int J Hematol; 1993 Aug 01; 58(1-2):21-6. PubMed ID: 7693027
    [Abstract] [Full Text] [Related]

  • 16. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM.
    Exp Hematol; 1993 Nov 01; 21(12):1583-90. PubMed ID: 7691640
    [Abstract] [Full Text] [Related]

  • 17. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F, Rappa DA, Laky K, Carsons SE.
    Stem Cells; 1995 Mar 01; 13(2):186-97. PubMed ID: 7540472
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human granulocyte colony stimulating factors: therapeutic application in the prevention of chemotherapy-induced neutropenia.
    Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MA, Clarkson B.
    Behring Inst Mitt; 1988 Aug 01; (83):229-33. PubMed ID: 2467654
    [No Abstract] [Full Text] [Related]

  • 19. Bladder carcinoma cell line KU-19-19-derived cytokines support proliferation of growth factor-dependent hematopoietic cell lines: modulation by phorbol ester, interferon-gamma and interleukin-1 beta.
    Steube KG, Meyer C, Tachibana M, Murai M, Drexler HG.
    Biochem Biophys Res Commun; 1998 Jan 26; 242(3):497-501. PubMed ID: 9464244
    [Abstract] [Full Text] [Related]

  • 20. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Symann ML.
    Cancer Res; 1993 Jul 01; 53(13):3139-44. PubMed ID: 8319222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.